Invention Grant
- Patent Title: T cell inhibitory receptor compositions and uses thereof
- Patent Title (中): T细胞抑制受体组合物及其用途
-
Application No.: US11339066Application Date: 2006-01-25
-
Publication No.: US08110189B2Publication Date: 2012-02-07
- Inventor: Richard S. Blumberg
- Applicant: Richard S. Blumberg
- Applicant Address: US MA Boston
- Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Agent David S. Resnick
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The invention relates to compositions which bind T cell inhibitory receptor molecules and modulate T cell activity, and methods of using such compositions. Such compositions include biliary glycoprotein binding agents. Methods for modulating killer T cell activities, including cytotoxicity and proliferation also are provided.
Public/Granted literature
- US20080102071A1 T cell inhibitory receptor compositions and uses thereof Public/Granted day:2008-05-01
Information query
